Is Syringocystadenoma Papilliferum Incidental in This Verrucous Carcinoma?-Reference-Cited by-同舟云学术

Is Syringocystadenoma Papilliferum Incidental in This Verrucous Carcinoma?

Published:2019-10-22 Issue: Volume:2019 Page:1-3
ISSN:2090-6781
Container-title:Case Reports in Pathology
language:en
Short-container-title:Case Reports in Pathology

Author:

Long Tyler¹^ORCID,Bonomo Brian²,Shearer Sydney¹,Welton William²,Massullo Ralph²,Gibbons George³

Affiliation:

1. Lake Erie College of Osteopathic Medicine, 5000 Lakewood Ranch Blvd, Bradenton, FL 34211, USA

2. Suncoast Dermatology, Lecanto, FL, USA

3. Medical Director—Dermpath Diagnostics Bay Area of Dermatopathology, Tampa, FL, USA

Abstract

This case report presents a case in which a collision tumor consisting of three separate pathological entities—a verrucous carcinoma (VC), syringocystadenoma papilliferum (SCAP), and a basal cell carcinoma (BCC). The presentation of this collision tumor is unexpected. It presented as an exophytic mass on the scalp. While collisions of SCAP and VC are present in the literature, this case included an additional pathologic entity. The association of these entities and the unreported location of the lesion may provide some further insight as to the etiology of VC.

Publisher

Hindawi Limited

Subject

General Medicine

Link

http://downloads.hindawi.com/journals/cripa/2019/1783758.pdf

Reference7 articles.

1. Syringadenoma Papilliferum

2. Verrucous carcinoma of the skin and mucosa

3. Syringocystadenoma Papilliferum of the Back Combined with a Tubular Apocrine Adenoma

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare cutaneous verrucous carcinoma in the femoral region: a case report;UNIVERSA MED;2023

2. Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors;Cancers;2022-01-18

Multiple Skin Neoplasms at One Site (MUSK IN A NEST): A Comprehensive Review of Basal Cell Carcinoma and Benign or Malignant “Collision” Tumors at the Same Cutaneous Location

;Clinical, Cosmetic and Investigational Dermatology;2020-09